Knowledge and Practices for SP Use in Intermittent Presumptive Treatment (IPT-sp) of Malaria Among Pregnant Women at Bugando Medical Centre.
Material type:
TextPublisher number: Wurzburg Road 35, BMC Premises, Post Code: 33102: P. O Box 1464, Mwanza – Tanzania:Phone: +255 28 298 3384: Fax: +255 28 298 3386: Email: vc@bugando.ac.tz : www.bugando.ac.tzLanguage: English Language: Kiswahili Publication details: Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS – Bugando] : ©2014Description: 32 Pages; Includes ReferencesSubject(s): Summary: Abstract:
Background: The standard treatment guideline of Tanzania mainland which was released in 2007 indicated that Artemether-Lumefantrine (ALU) should be used as the first line for malaria treatment instead of Sulphadoxine-Pyrimethamine (SP) with this change it was still advocated that pregnant women should continue to take SP for Intermittent Preventive Treatment (IPT) of malaria during pregnancy. Hence, despite increasing prevalence of malaria parasite resistance to SP, SP continues to be recommended for intermittent preventive treatment in pregnancy (IPTp).
Method: The study was conducted from May 2014 to July 2014 at Bugando medical centre. Three hundred and eighty four (384) pregnant women were interviewed.
Results: About (33.3%, n=128) of pregnant women did not know if SP was used for IPT. Most women (56.8%, n=218) did not know the use of SP for IPT in relationship with gestation age, only (8.6%, n=33) mentioned three doses of SP are acquired for a pregnant women and (59.4%, n=228) did not know the interval between one dose to another. One hundred seventy seven (46.1%, n=177) pregnant women reported to have had malaria during their current pregnancies.
Conclusion: Most pregnant women had minimum knowledge about the use and benefits of SP for IPT. For effective implementation of IPT policy, pregnant women should be sensitized and educated on the use and benefits of SP for IPT.
| Item type | Current library | Collection | Status | Barcode | |
|---|---|---|---|---|---|
| UNDERGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | 1 | UD0322 |
Abstract:
Background: The standard treatment guideline of Tanzania mainland which was released in 2007 indicated that Artemether-Lumefantrine (ALU) should be used as the first line for malaria treatment instead of Sulphadoxine-Pyrimethamine (SP) with this change it was still advocated that pregnant women should continue to take SP for Intermittent Preventive Treatment (IPT) of malaria during pregnancy. Hence, despite increasing prevalence of malaria parasite resistance to SP, SP continues to be recommended for intermittent preventive treatment in pregnancy (IPTp).
Method: The study was conducted from May 2014 to July 2014 at Bugando medical centre. Three hundred and eighty four (384) pregnant women were interviewed.
Results: About (33.3%, n=128) of pregnant women did not know if SP was used for IPT. Most women (56.8%, n=218) did not know the use of SP for IPT in relationship with gestation age, only (8.6%, n=33) mentioned three doses of SP are acquired for a pregnant women and (59.4%, n=228) did not know the interval between one dose to another. One hundred seventy seven (46.1%, n=177) pregnant women reported to have had malaria during their current pregnancies.
Conclusion: Most pregnant women had minimum knowledge about the use and benefits of SP for IPT. For effective implementation of IPT policy, pregnant women should be sensitized and educated on the use and benefits of SP for IPT.
There are no comments on this title.